MannKind Corporation (Nasdaq: MNKD) and Pfizer Inc (NYSE: PFE) announced that MannKind will transition certain Exubera patients with a continuing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE